Little Green Pharma's (ASX: LGP) new Denmark facility to underpin European growth strategy (w/ Fleta Solomon)

Little Green Pharma (ASX: LGP) managing director Fleta Solomon joins Small Caps to discuss the company’s growth plans with the acquisition of a world class cultivation and GMP medicinal cannabis facility in Denmark. The acquisition is part of Little Green Pharma’s strategy to penetrate the EU with a first mover advantage. A recent $27.2 million placement was significantly supported by mining company Hancock Prospecting which contributed $15 million.See omnystudio.com/listener for privacy information.